ReviewNPJ breast cancer2021
HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now.
Ilana Schlam et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
155 papers cite itlatest 60 shown
this paperpooled itcites it